STTK

Shattuck Labs, Inc. is a clinical-stage biotechnology firm headquartered in Austin, Texas, specializing in the development of innovative therapies for cancer and autoimmune diseases. Utilizing its proprietary technology platforms, the company focuses on creating targeted treatments that address critical unmet medical needs in the healthcare landscape. With a robust commitment to research and development, Shattuck Labs aims to significantly enhance patient outcomes by delivering next-generation therapeutics, positioning itself as a competitive player in the biopharmaceutical industry.